Hindustan Unilever Ltd. has filed an appeal with the income tax appellate authority, challenging a demand of over Rs 962.75 ...

Commenting on the macroeconomic reality and its impact on the industrial sector, the Chartered Institute of Directors (CIoD) ...

GSK announced positive results from two phase 3 clinical trials evaluating its experimental drug, depemokimab, for chronic rhinosinusitis with nasal polyps affecting 4% of the population.

Antiviral Drugs MarketThe antiviral drugs market is anticipated to experience significant growth, flourishing at an average ...

GSK announced another batch of positive data from its respiratory program with the investigational drug depemokimab, this ...

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce ...

The global airway disease treatment market is projected to experience significant growth over the next decade, with revenue ...

Nigeria’s healthcare sector, though growing steadily, remains significantly inadequate in the broader economy, according to financial analyst and CEO of ...

It’s the thing and agency dreads – the repitch. But this year there could be a bumper crop of repitches just around the ...

GSK’s blockbuster hopes for depemokimab remain on track after the investigational long-acting asthma treatment has also been ...

GSK said that both the Anchor-1 and Anchor-2 trials met their co-primary endpoints of a change from baseline in total endoscopic nasal polyp score after 52 weeks, as well as a change in mean nasal ...

GSK Plc’s experimental drug to treat a common inflammatory nasal condition showed positive results in two late-stage trials ...